Medicines in Russia — Towards Interdisciplinary Dialogue
XIV Partnering will bring together representatives of regulatory authorities, the pharmaceutical industry, the scientific community and professional associations.
The agenda will focus on pharmacovigilance, access to medicines, regulatory practice, cooperation among EAEU member states and issues directly affecting the quality and safety of pharmacotherapy.
Who Partnering Brings Together
The event brings regulators, industry representatives, scientists and the professional community together on one platform.
Regulatory authorities of Russia and EAEU member states
Pharmaceutical industry
Scientific and medical community
Professional and patient organisations
Organisers and Partners
Key Topics
Pharmacovigilance
Development of safety monitoring systems and modern regulatory practice.
EAEU
Harmonisation of approaches among member states and interstate dialogue.
Regulatory dialogue
Interaction between industry, the expert community and public authorities.
Access to medicines
Systemic and practical issues related to access to pharmacotherapy.
Public procurement
Current practice and key issues in medicines procurement and supply.
Quality of life
Treatment safety, patient interests and the quality of pharmacovigilance.
XIV Partnering Programme
The programme is currently being developed and will be available soon.
Speakers
Ivan Anosov
Chairman
Association for Pharmacovigilance
Igor Kaminsky
Deputy General Director for Quality Assurance and Scientific Affairs
Pharmcompliance LLC
More speakers to be announced
Speaker information will be published later
More speakers to be announced
Speaker information will be published later
A Professional Platform with a Proven Track Record
“The event demonstrated significant progress in international cooperation among EAEU countries in developing common approaches to pharmacovigilance systems. The discussion of practical cases and prospects for improving pharmacovigilance legislation was an important step towards harmonising regulatory requirements.”
“Participating in the conference was a truly vivid and valuable experience. The professionals who presented their ideas outlined a course towards the progressive development of pharmacovigilance, helping to strengthen best practices both in the EAEU and the EU.”
Participation Formats
Kaliningrad
- access to all in-person sessions
- access to event materials
- professional networking
- coffee breaks and networking areas
Online
- live online access to the main sessions
- access to event materials
- participation from any location
- no travel expenses
Venue
Highlights from XIII Partnering
Main hall · XIII Partnering
Participant networking
Frequently Asked Questions
24–25 September 2026 · Kaliningrad
XIV Partnering is a professional dialogue on quality, safety and the future of pharmacotherapy.